New Square Capital LLC Edwards Lifesciences Corp Transaction History

New Square Capital LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	BUY	$61.71 - $77.76 $6,171 - $7,776	100 New	100 $7,000
Q1 2022 May 10, 2022	SELL	$101.96 - $128.34 $7,646 - $9,625	-75 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$71.69 - $91.23 $5,376 - $6,842	75 New	75 $7,000
Q1 2020 May 08, 2020	SELL	$52.41 - $81.0 $0 - $0	0 Closed	0 $0
Q4 2019 Jan 10, 2020	BUY	$71.7 - $82.09 $0 - $0	0 New	0 $0
Q1 2019 Apr 25, 2019	SELL	$47.89 - $64.05 $3,208 - $4,291	-67 Closed	0 $0
Q1 2018 Apr 24, 2018	SELL	$37.19 - $47.45 $2,454 - $3,131	-66 Reduced 49.62%	67 $9,000
Q4 2017 Jan 29, 2018	SELL	$33.79 - $39.39 $2,263 - $2,639	-67 Reduced 33.5%	133 $15,000
Q3 2017 Nov 07, 2017	BUY	$36.29 - $38.83 $7,258 - $7,766	200	200 $22,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of New Square Capital LLC, based on Form 13F filings with the SEC.

Stay updated on New Square Capital LLC with notifications on news.